Aerie Pharmaceuticals Inc

VANGUARD GROUP INC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

2,441,120

Value ($000)

36,933

Weight

0.0%

2013 Q4 - 2022 Q3 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	36,933	0.0%	2,441,120	9/30/2022
2022 Q2	8/12/2022	20,397	0.0%	2,719,487	6/30/2022
2022 Q1	5/13/2022	23,291	0.0%	2,559,480	3/31/2022
2021 Q4	2/14/2022	23,736	0.0%	3,381,368	12/31/2021
2021 Q3	11/12/2021	49,895	0.0%	4,376,806	9/30/2021
2021 Q2	8/13/2021	69,639	0.0%	4,349,682	6/30/2021
2021 Q1	5/14/2021	75,962	0.0%	4,250,754	3/31/2021
2020 Q4	2/12/2021	56,973	0.0%	4,217,071	12/31/2020
2020 Q3	11/16/2020	47,498	0.0%	4,035,457	9/30/2020
2020 Q2	8/14/2020	62,873	0.0%	4,259,708	6/30/2020
2020 Q1	5/15/2020	58,629	0.0%	4,342,814	3/31/2020
2019 Q4	2/14/2020	102,421	0.0%	4,237,491	12/31/2019
2014 Q2	8/11/2014	4,791	0.0%	193,405	6/30/2014
2014 Q1	5/13/2014	3,465	0.0%	163,483	3/31/2014
2013 Q4	2/12/2014	1,654	0.0%	92,100	12/31/2013